BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 26979597)

  • 1. Genome-wide gene expression analyses reveal unique cellular characteristics related to the amenability of HPC/HSCs into high-quality induced pluripotent stem cells.
    Gao S; Tao L; Hou X; Xu Z; Liu W; Zhao K; Guo M; Wang H; Cai T; Tian J; Gao S; Chang G
    Stem Cell Res Ther; 2016 Mar; 7():40. PubMed ID: 26979597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis of hematopoietic differentiation outcomes and molecular characterization reveals unbiased differentiation capacity and minor transcriptional memory in HPC/HSC-iPSCs.
    Gao S; Hou X; Jiang Y; Xu Z; Cai T; Chen J; Chang G
    Stem Cell Res Ther; 2017 Jan; 8(1):13. PubMed ID: 28114969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleosome organizations in induced pluripotent stem cells reprogrammed from somatic cells belonging to three different germ layers.
    Tao Y; Zheng W; Jiang Y; Ding G; Hou X; Tang Y; Li Y; Gao S; Chang G; Zhang X; Liu W; Kou X; Wang H; Jiang C; Gao S
    BMC Biol; 2014 Dec; 12():109. PubMed ID: 25528259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts.
    Pomeroy JE; Hough SR; Davidson KC; Quaas AM; Rees JA; Pera MF
    Stem Cells Transl Med; 2016 Jul; 5(7):870-82. PubMed ID: 27160704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-High-Frequency Reprogramming of Individual Long-Term Hematopoietic Stem Cells Yields Low Somatic Variant Induced Pluripotent Stem Cells.
    Wang K; Guzman AK; Yan Z; Zhang S; Hu MY; Hamaneh MB; Yu YK; Tolu S; Zhang J; Kanavy HE; Ye K; Bartholdy B; Bouhassira EE
    Cell Rep; 2019 Mar; 26(10):2580-2592.e7. PubMed ID: 30840883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated HoxB4-induced hematopoietic stem cells from murine pluripotent stem cells via long-term programming.
    Izawa K; Yamazaki S; Becker HJ; Bhadury J; Kakegawa T; Sakaguchi M; Tojo A
    Exp Hematol; 2020 Sep; 89():68-79.e7. PubMed ID: 32795499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapy.
    Navarro S; Moleiro V; Molina-Estevez FJ; Lozano ML; Chinchon R; Almarza E; Quintana-Bustamante O; Mostoslavsky G; Maetzig T; Galla M; Heinz N; Schiedlmeier B; Torres Y; Modlich U; Samper E; Río P; Segovia JC; Raya A; Güenechea G; Izpisua-Belmonte JC; Bueren JA
    Stem Cells; 2014 Feb; 32(2):436-46. PubMed ID: 24420904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
    Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
    Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum starvation-induced cell cycle synchronization stimulated mouse rDNA transcription reactivation during somatic cell reprogramming into iPSCs.
    Zhao Q; Wu Y; Shan Z; Bai G; Wang Z; Hu J; Liu L; Li T; Shen J; Lei L
    Stem Cell Res Ther; 2016 Aug; 7(1):112. PubMed ID: 27515169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the early and late responder genes during the generation of induced pluripotent stem cells from mouse fibroblasts.
    Park J; Kwon YW; Ham S; Hong CP; Seo S; Choe MK; Shin SI; Lee CS; Kim HS; Roh TY
    PLoS One; 2017; 12(2):e0171300. PubMed ID: 28152015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cells from induced pluripotent stem cells - considering the role of microRNA as a cell differentiation regulator.
    Ferreira AF; Calin GA; Picanço-Castro V; Kashima S; Covas DT; de Castro FA
    J Cell Sci; 2018 Feb; 131(4):. PubMed ID: 29467236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells.
    Sugimura R
    Methods Mol Biol; 2019; 2005():37-41. PubMed ID: 31175644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide mapping of miRNAs expressed in embryonic stem cells and pluripotent stem cells generated by different reprogramming strategies.
    Zhao B; Yang D; Jiang J; Li J; Fan C; Huang M; Fan Y; Jin Y; Jin Y
    BMC Genomics; 2014 Jun; 15(1):488. PubMed ID: 24942538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Fetal Bovine Serum (FBS) on Efficacy of Cellular Reprogramming for Induced Pluripotent Stem Cell (iPSC) Generation.
    Kwon D; Kim JS; Cha BH; Park KS; Han I; Park KS; Bae H; Han MK; Kim KS; Lee SH
    Cell Transplant; 2016; 25(6):1025-42. PubMed ID: 26450367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global epigenetic changes during somatic cell reprogramming to iPS cells.
    Mattout A; Biran A; Meshorer E
    J Mol Cell Biol; 2011 Dec; 3(6):341-50. PubMed ID: 22044880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative Routes to Induced Pluripotent Stem Cells Revealed by Reprogramming of the Neural Lineage.
    Jackson SA; Olufs ZP; Tran KA; Zaidan NZ; Sridharan R
    Stem Cell Reports; 2016 Mar; 6(3):302-11. PubMed ID: 26905202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global transcriptional analysis of nuclear reprogramming in the transition from MEFs to iPSCs.
    Dong F; Song Z; Zhang J; Lu Y; Song C; Jiang B; Zhang B; Cong P; Sun H; Shi F; Liu H
    Genes Cells; 2013 Jan; 18(1):42-55. PubMed ID: 23231677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell type-specific expression profile and signaling requirements in early hematopoietic reprogramming.
    Kang L; Wu J; Tao Y; Li H; Liu X; Gao S; Wang QF
    Stem Cells Dev; 2015 Jun; 24(12):1483-92. PubMed ID: 25751301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.
    Choi HW; Kim JH; Chung MK; Hong YJ; Jang HS; Seo BJ; Jung TH; Kim JS; Chung HM; Byun SJ; Han SG; Seo HG; Do JT
    Stem Cells Dev; 2015 Jun; 24(11):1366-73. PubMed ID: 25590788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations.
    Salci KR; Lee JH; Laronde S; Dingwall S; Kushwah R; Fiebig-Comyn A; Leber B; Foley R; Dal Cin A; Bhatia M
    Stem Cells; 2015 Jun; 33(6):1839-49. PubMed ID: 25764124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.